Guangzhou Hospital and Guangdong Emerging Laser and Plasma Technology Research Institute Team Up to Develop Next-Generation Cancer Treatment Device
Published: 12 Mar 2026
Author: Precedence Research
In March 2026, the Fifth Affiliated Hospital of Guangzhou Medical University and the Guangdong Emerging Laser and Plasma Technology Research Institute have collaborated to develop a new generation of electron beam devices for cancer therapy. This partnership is expected to propel the advancement of precise radiotherapy techniques and explore new avenues for the effective treatment of cancer.
Focus on Precision and Efficiency
This new electron beam accelerator is expected to be a compact device that could possibly provide a more efficient treatment for cancer. The senior doctors from the hospital stressed the significance of gaining clinical experience and cutting-edge research, noting that such collaboration between medical practitioners and technology experts could speed up the innovation process. The research institute also explained that the initiative would include the possibility of simplifying the technology, reducing costs and improving safety and efficacy.
The global intensity modulated radiotherapy market size was calculated at USD 2.71 billion in 2025 and is predicted to increase from USD 2.89 billion in 2026 to approximately USD 5.10 billion by 2035, expanding at a CAGR of 6.52% from 2026 to 2035 as the demand grows for advanced cancer treatment technologies that provide accurate outcomes in a safe manner.
A Step Towards Innovation in Cancer Care
This collaboration has been recognized by experts as an example of the efficiency of medical institutions and research centers working together for the development of technology for the greater good. This partnership on electron beam technology is seen as an effort towards the development of precision cancer treatments that are not only effective but also flexible enough for various medical needs. As the collaboration is inaugurated, the focus is on the research results that are set to be released in the coming months, which could provide opportunities for the development of high-precision cancer therapy and the advancement of innovative radiotherapy technologies.
Such initiatives have also found support from local government agencies, who believe that these technologies could help Guangzhou become a center of medical technology. The success of this device could lead to future advancements in cancer treatment equipment, as well as development of precision radiotherapy.
A recent report by Precedence Research highlights that the intensity modulated radiotherapy market is benefiting from the collaborations between hospitals and research institutions, as well as developments in radiation technology and government initiatives.